The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms.

Zaina, S; Squire, S

Zaina, S; Squire, S.

Affiliation

Zaina S; Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, United Kingdom. Silvio.Zaina@medforsk.mas.lu.se

J Biol Chem ; 273(44): 28610-6, 1998 Oct 30.

Article in En | MEDLINE | ID: mdl-9786853

Subject(s)

Insulin-Like Growth Factor II/metabolism; Receptors, Somatomedin/physiology; Animals; Base Sequence; Crosses, Genetic; DNA Primers; Heterozygote; Mice; Mice, Transgenic; Organ Size; Phenotype; Receptors, Somatomedin/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Insulin-Like Growth Factor II / Receptors, Somatomedin Limits: Animals Language: En Journal: J Biol Chem Year: 1998 Document type: Article

Search on Google

XML

PubMed Links